Author Archives: Reid Paul

Witty Touts GSK Pipeline in 4th Quarter Review

Posted in Emerging Markets, Europe, Global, News, R&D, Strategy | Tagged , , , , , , | Leave a comment

Pfizer Proactive in Birth Control Pill Recall

Posted in Events, FDA, Legal, Safety, Strategy | Tagged | Leave a comment

Supreme Court Strikes down Vermont Law, Upholds Rep Free Speech

June 23rd was a good day for the pharmaceutical industry. The Supreme Court released two decisions that largely went pharma’s way. There was much rejoicing across the industry, and for good reason, business as usual won out. In PLIVA v. Mensing, the Court ruled that generic drug companies should comply with federal regulations instead of […]
Posted in Legal | Tagged , , , | Leave a comment

Big Pharma Reps Still Competing with Local Players in Emerging Markets

Although pharma is an increasingly global marketplace, the relative rankings of companies are becoming more localized — with significant variations — according to a new Cegedim survey of physician attitudes towards reps in the major western markets and Brazil, India, Russia, and China. According to the International Rep Quality survey, physicians tend to favor domestic […]
Posted in Emerging Markets, Europe, Guest Blog, Marketing, Sales | Tagged , , , , , , | Leave a comment

Mass Gift Ban Repeal Efforts Fizzle

An effort in the Massachusetts legislature to repeal the state’s ban on many gifts to healthcare providers has failed. The year-old ban is considered one of the most restrictive in the country, banning restaurant meals, various gifts and requiring reporting on transfers of value above $50. “This repeal effort was started by legislators concerned that […]
Posted in Legal | Tagged , , , , , , , | 1 Comment
  • Categories

  • Meta